Serigne Lo

[Professor Georgina Long AO (Bluesky @gvlongphdmd) @ProfGLongMIA]

Thrilled to celebrate three outstanding colleagues at @MelanomaAus! Huge congratulations to Professor Alex Menzies, Professor Sydney Ch’ng and Professor Serigne Lo on their well-deserved promotions to Professor at @sydney_uni. All exceptional researchers who are making a real difference in #melanoma research.
@SerineLo #AlexMenzies @drsydneychng @Science_Academy @FulbrightAUS @AAHMS_health @ausoftheyear

[JAMA Dermatology @JAMADerm]

Risk of melanoma-related death increased significantly for patients with primary tumors of 0.8 to 1.0 mm in thickness. https://t.co/wS6txeLjgu

[Melanoma Institute Australia @MelanomaAus]

A/Prof @SerineLo leads a team responsible for the design & analysis of clinical trials, and the development of tools that guide the treatment of melanoma patients. You can deep-dive into his life and research in our latest #LabLife blog > https://t.co/jUuJ2EVA6k
#melanoma

[Melanoma Institute Australia @MelanomaAus]

In a significant step for personalised cancer treatment, a new online #ImmunotherapyOutcomesPrediction tool developed by MIA will help determine if advanced melanoma patients will respond to #immunotherapy. @inespiresilva @amenzies9
https://t.co/V9f8HS6McO

[Melanoma Institute Australia @MelanomaAus]

Today MIA launched a world-first online calculator, the #ImmunotherapyOutcomesPrediction tool, to predict an advanced melanoma patient’s response to immunotherapy. A vital advance in personalising cancer treatment. @gabyrogers shared the story on #9News. @inespiresilva @amenzies9

[Melanoma Institute Australia @MelanomaAus]

MIA's new #ImmunotherapyOutcomesPrediction online calculator, allows oncologists to assess patient's response to immunotherapy & plan personalised treatment. Saving lives, & reducing physical, emotional & financial burden. @TomHartley_7 #7NEWS @syd_health https://t.co/nzJPwqOB2T

[Professor Georgina Long AO (Bluesky @gvlongphdmd) @ProfGLongMIA]

Proud of MIA researcher @_graceattrill, lead author on this paper published in #JITC. A significant discovery by the MIA team in our quest to improve outcomes for immunotherapy-treated patients. @JWilmott38 #immunotherapy

[Roger Olofsson Bagge @OlofssonBagge]

Serigne Lo: the man defining the new speciality of “Statistical oncology”! ⁦⁩The man that creates all the magic for the colleagues ⁦@ProfGLongMIA, Alex van Akkooi and colleagues at ⁦@MelanomaAus⁩ Glad to meet him at #ASCO22

[Melanoma Institute Australia @MelanomaAus]

Congrats to @AnneECust , @SerineLo and @AlexVarey & their teams for bringing the MIA Melanoma Risk Calculators to realisation. Have you checked your melanoma risk? https://t.co/Z4SFv1stF5

[Professor Richard Scolyer AO @ProfRAScolyer]

#melanoma doesn’t stop in a pandemic- use our @MelanomaAus online calculators at https://t.co/VWD6DuoRXM to calculate your individual risk- prevention & early detection key to saving lives! @ProfGLongMIA @AnneECust @AlexVarey @SerineLo

[Professor Richard Scolyer AO @ProfRAScolyer]

Below is 1st of series of publictns from outstanding @MelanomaAus visiting Dutch dermatologist scholar MaryAnn El Sharouni:
Predicting recurrence in pts with sentinel node‐neg #melanoma: validation of EORTC nomogram using population‐based data https://t.co/yg37tuHWZ7 @SerineLo

[Serigne Lo @SerineLo]

Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram https://t.co/sCSb5CHngs

[Serigne Lo @SerineLo]

#SkyViewTijnelomoctAR

[Serigne Lo @SerineLo]

@croakeyblog